Neurologic sequelae associated with foscarnet therapy

OBJECTIVE: To report three cases of possible foscarnet-induced neurologic sequelae. CASE SUMMARY: We report two cases of seizures and one case of hand cramping and finger paresthesia after starting foscarnet therapy with no evidence of predisposing risk factors, such as serum laboratory abnormalities, renal dysfunction, or known central nervous system (CNS) involvement. All three patients had stable laboratory values during therapy and when the neurologic adverse effects occurred. All patients were receiving appropriate dosages of foscarnet. DISCUSSION: The incidence of seizures in AIDS patients was reviewed. A history of CNS lesions, infections, and/or AIDS per se may increase the risk of a neurologic adverse effect while receiving foscarnet therapy. Acute ionized hypocalcemia may cause these neurologic adverse effects. Ionized hypocalcemia is transitory, is related to the rate of foscarnet infusion, and may not be reflected as a change in total serum calcium concentration. CONCLUSIONS: Foscarnet probably contributed to the neurologic adverse effects reported here. Foscarnet may need to be administered at a slower rate than is recommended by the manufacturer. Electrolytes must be monitored closely; however, a neurologic adverse effect may not be foreseen.

This article has been cited by other articles:

				M. M. Huycke, M. T. Naguib, M. M. Stroemmel, K. Blick, K. Monti, S. Martin-Munley, and C. Kaufman A Double-Blind Placebo-Controlled Crossover Trial of Intravenous Magnesium Sulfate for Foscarnet-Induced Ionized Hypocalcemia and Hypomagnesemia in Patients with AIDS and Cytomegalovirus Infection Antimicrob. Agents Chemother., August 1, 2000; 44(8): 2143 - 2148. [Abstract] [Full Text]

				R. K. Garg HIV medicine: HIV infection and seizures Postgrad. Med. J., July 1, 1999; 75(885): 387 - 390. [Abstract] [Full Text]

				H. Matsuo, M. Ryu, A. Nagata, T. Uchida, J.-I. Kawakami, K. Yamamoto, T. Iga, and Y. Sawada Neurotoxicodynamics of the Interaction between Ciprofloxacin and Foscarnet in Mice Antimicrob. Agents Chemother., March 1, 1998; 42(3): 691 - 694. [Abstract] [Full Text]